Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Return on Assets (2016 - 2025)

Fennec Pharmaceuticals' Return on Assets history spans 15 years, with the latest figure at 0.05% for Q4 2025.

  • For the quarter ending Q4 2025, Return on Assets fell 5.0% year-over-year to 0.05%, compared with a TTM value of 0.05% through Dec 2025, down 5.0%, and an annual FY2025 reading of 0.17%, down 50.0% over the prior year.
  • Return on Assets for Q4 2025 was 0.05% at Fennec Pharmaceuticals, up from 0.14% in the prior quarter.
  • The five-year high for Return on Assets was 0.07% in Q1 2024, with the low at 1.27% in Q2 2023.
  • Average Return on Assets over 5 years is 0.53%, with a median of 0.64% recorded in 2021.
  • Year-over-year, Return on Assets surged 132bps in 2024 and then crashed -37bps in 2025.
  • Tracing FENC's Return on Assets over 5 years: stood at 0.61% in 2021, then tumbled by -36bps to 0.82% in 2022, then grew by 18bps to 0.67% in 2023, then surged by 101bps to 0.0% in 2024, then plummeted by -1445bps to 0.05% in 2025.
  • Per Business Quant, the three most recent readings for FENC's Return on Assets are 0.05% (Q4 2025), 0.14% (Q3 2025), and 0.25% (Q2 2025).